RxDoctor Payments Data

Chuan-Hao Lin

Pediatric Gastroenterology · Los Angeles, CANPI 1285734921

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,490 of the $6,204 with a category attached, or 72.4%. Gilead accounts for 96.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $6,009 and has fallen 99.7% since, to $15 in 2025.

$6,204in general payments, 2019–2025

Across 45 payments — averaging $137.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$6K
  • Travere Therapeutics, Inc.$144
  • AbbVie$45
  • Mirum Pharmaceuticals, Inc.$39
  • Covidien LP$18
$536,164in research payments, 2019–2025

Across 130 payments — averaging $4124.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mirum Pharmaceuticals, Inc.$273K
  • Gilead$247K
  • Albireo Pharma, Inc.$17K

What the payments were for

  • Consulting fees$4,49072%
  • Travel & lodging$1,16619%
  • Food & beverage$4047%
  • Education$1442%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,204 in reported general payments places this provider in the 85th percentile of 220 pediatric gastroenterology providers in California.

See all pediatric gastroenterology providers in California

Other pediatric gastroenterology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →